Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Safer introduction of new health technologies.

Arentz-Hansen H, Hafstad E, Lauvrak V, Stoinska-Schneider A, Vang VJ, Ormstad S, Fure B.

Tidsskr Nor Laegeforen. 2018 May 28;138(9). doi: 10.4045/tidsskr.17.0716. Print 2018 May 29. English, Norwegian. No abstract available.

2.

Sutureless Aortic Valve Replacement for Treatment of Severe Aortic Stenosis: A Single Technology Assessment of Perceval Sutureless Aortic Valve [Internet].

Desser AS, Arentz-Hansen H, Fagerlund BF, Harboe I, Lauvrak V.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Aug 25.

3.

Non-Invasive Prenatal Test (NIPT) for Identification of Trisomy 21, 18 and 13 [Internet].

Juvet LK, Ormstad SS, Stoinska‐Schneider A, Solberg B, Arentz‐Hansen H, Kvamme MK, Fure B.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2016 Dec 16.

4.

Determination of Fetal Rhesus D Status from Maternal Plasma of Rhesus Negative Women [Internet].

Arentz-Hansen H, Brurberg KG, Kvamme MK, Stoinska-Schneider A, Hofmann B, Ormstad SS, Fure B.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2014 Dec.

5.

Effect of Multidisciplinary, Team-Based Rehabilitation, Including Education, in Rheumatoid Arthritis [Internet].

Arentz-Hansen H, Smedslund G, Kvalvik AG, Dagfinrud H, Fure B.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2012 Dec.

6.

Left Ventricular Assist Device (LVAD) as Destination Therapy for Patients with Endstage Heartfailure [Internet].

Lauvrak V, Skår Å, Arentz-Hansen H, Hamidi V, Fure B.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2013 Nov.

7.

Tumor Necrosis Factor (TNF) Inhibitors for Rheumatic Diseases (Part 2): A Systematic Review of Data From Registries and Safety Databases [Internet].

Arentz-Hansen H, Palm Ø, Natvig Norderhaug I, Klemp Gjertsen M, Nordvåg BY.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2007 Feb.

8.

GUIDING PRINCIPLES FOR GOOD PRACTICES IN HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT UNITS.

Sampietro-Colom L, Lach K, Pasternack I, Wasserfallen JB, Cicchetti A, Marchetti M, Kidholm K, Arentz-Hansen H, Rosenmöller M, Wild C, Kahveci R, Ulst M.

Int J Technol Assess Health Care. 2015;31(6):457-65. doi: 10.1017/S0266462315000732. Epub 2016 Feb 22.

PMID:
26899230
9.

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.

Tollefsen S, Arentz-Hansen H, Fleckenstein B, Molberg O, Ráki M, Kwok WW, Jung G, Lundin KE, Sollid LM.

J Clin Invest. 2006 Aug;116(8):2226-36. Epub 2006 Jul 27.

10.

Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.

Shan L, Qiao SW, Arentz-Hansen H, Molberg Ø, Gray GM, Sollid LM, Khosla C.

J Proteome Res. 2005 Sep-Oct;4(5):1732-41.

11.

Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease.

Molberg O, Uhlen AK, Jensen T, Flaete NS, Fleckenstein B, Arentz-Hansen H, Raki M, Lundin KE, Sollid LM.

Gastroenterology. 2005 Feb;128(2):393-401.

PMID:
15685550
12.

The molecular basis for oat intolerance in patients with celiac disease.

Arentz-Hansen H, Fleckenstein B, Molberg Ø, Scott H, Koning F, Jung G, Roepstorff P, Lundin KE, Sollid LM.

PLoS Med. 2004 Oct;1(1):e1. Epub 2004 Oct 19.

13.

Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease.

Molberg Ø, Solheim Flaete N, Jensen T, Lundin KE, Arentz-Hansen H, Anderson OD, Kjersti Uhlen A, Sollid LM.

Gastroenterology. 2003 Aug;125(2):337-44.

PMID:
12891534
14.

Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.

Arentz-Hansen H, McAdam SN, Molberg Ø, Fleckenstein B, Lundin KE, Jørgensen TJ, Jung G, Roepstorff P, Sollid LM.

Gastroenterology. 2002 Sep;123(3):803-9.

PMID:
12198706
15.

Staining of celiac disease-relevant T cells by peptide-DQ2 multimers.

Quarsten H, McAdam SN, Jensen T, Arentz-Hansen H, Molberg Ø, Lundin KE, Sollid LM.

J Immunol. 2001 Nov 1;167(9):4861-8.

16.

Genes and environment in celiac disease.

Sollid LM, McAdam SN, Molberg O, Quarsten H, Arentz-Hansen H, Louka AS, Lundin KE.

Acta Odontol Scand. 2001 Jun;59(3):183-6.

PMID:
11501889
17.

T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.

Molberg O, McAdam S, Lundin KE, Kristiansen C, Arentz-Hansen H, Kett K, Sollid LM.

Eur J Immunol. 2001 May;31(5):1317-23.

18.

The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.

Arentz-Hansen H, Körner R, Molberg O, Quarsten H, Vader W, Kooy YM, Lundin KE, Koning F, Roepstorff P, Sollid LM, McAdam SN.

J Exp Med. 2000 Feb 21;191(4):603-12.

Supplemental Content

Loading ...
Support Center